Qudexy xr and Paraesthesia - a phase IV clinical study of FDA data

Summary:

Paraesthesia is reported as a side effect among people who take Qudexy xr (topiramate), especially for people who are female, 40-49 old, have been taking the drug for 1 - 6 months also take Cymbalta, and have Migraine.

The phase IV clinical study analyzes which people have Paraesthesia when taking Qudexy xr. It is created by eHealthMe based on reports of 276 people who have side effects when taking Qudexy xr from the FDA, and is updated regularly.

What is Qudexy xr?

Qudexy xr has active ingredients of topiramate. eHealthMe is studying from 282 Qudexy xr users. Check the latest studies of Qudexy xr.

What is Paraesthesia?

Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect) is found to be associated with 2,689 drugs and 3,120 conditions by eHealthMe. Check the latest studies of Paraesthesia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

276 people reported to have side effects when taking Qudexy xr.
Among them, 19 people (6.88%) have Paraesthesia.

Among these 19 people:

How long have people been on Qudexy xr when they have Paraesthesia? *

What is the gender of people who have Paraesthesia when taking Qudexy xr? *

female: 100 %
male: 0.0 %

What is the age of people who have Paraesthesia when taking Qudexy xr? *

What are other drugs people take besides Qudexy xr? *

What are other side effects people have besides Paraesthesia? *

Hypoaesthesia (reduced sense of touch or sensation): 8 people, 42.11%
Fatigue (feeling of tiredness): 8 people, 42.11%
Visual Impairment: 6 people, 31.58%
Memory Loss: 6 people, 31.58%
Nerve Injury: 6 people, 31.58%
Neuropathy Peripheral (surface nerve damage): 6 people, 31.58%
Numbness And Tingling (unusual prickling sensations): 6 people, 31.58%
Speech Impairment (Adult) (inability to speak (adult)): 5 people, 26.32%
Thinking Abnormal: 5 people, 26.32%
Pain: 4 people, 21.05%

What are the existing conditions these people have? *

Pain: 6 people, 31.58%
Neuropathy Peripheral (surface nerve damage): 6 people, 31.58%
Essential Tremor: 6 people, 31.58%
Migraine (headache): 6 people, 31.58%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 10.53%
High Blood Cholesterol: 2 people, 10.53%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 1 person, 5.26%
Arthropathy: 1 person, 5.26%
Bipolar Disorder (mood disorder): 1 person, 5.26%
Cardiac Disorder: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Qudexy xr and have Paraesthesia?

- Check whether Paraesthesia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Qudexy xr:

Qudexy xr (282 reports)

Paraesthesia treatments and more:

Paraesthesia (184,215 reports)

Browse all side effects of Qudexy xr:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Paraesthesia:

Paraesthesia (2,689 drugs)

Browse all the conditions that are associated with Paraesthesia:

Paraesthesia (3,120 conditions)

Related publications that referenced our studies

Baloch M, Siddiqui MA, "Topiramate induced sudden loss of vision", JPMA, 2012 Oct .
Kocamaz, M., & Karadag, O., "Topiramate-Induced Acute Myopia, Diplopia, and Photosensitivity: A Case Report", Beyoglu Eye Journal, 2019 Jan .
Baloch M, Siddiqui MA, "Topiramate induced sudden loss of vision", JPMA, 2012 Oct .
Kocamaz, M., & Karadag, O., "Topiramate-Induced Acute Myopia, Diplopia, and Photosensitivity: A Case Report", Beyoglu Eye Journal, 2019 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on topiramate (the active ingredients of Qudexy xr) and Qudexy xr (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.